Published in PLoS One on April 08, 2011
Rate of decline in CD4 count in HIV patients not on antiretroviral therapy. Med J Armed Forces India (2013) 1.08
Adherence to highly active antiretroviral treatment in HIV-infected Rwandan women. PLoS One (2011) 0.86
Should malaria treatment be guided by a point of care rapid test? A threshold approach to malaria management in rural Burkina Faso. PLoS One (2013) 0.82
The basis for monitoring strategies in clinical guidelines: a case study of prostate-specific antigen for monitoring in prostate cancer. CMAJ (2011) 0.82
Factors affecting timing of antiretroviral treatment initiation based on monitoring CD4 counts. J Acquir Immune Defic Syndr (2012) 0.75
Reply. Med J Armed Forces India (2014) 0.75
Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet (2002) 16.56
Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med (1997) 16.44
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet (2009) 14.01
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA (2010) 9.26
Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N Engl J Med (2010) 8.72
Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA (2006) 7.14
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood (2004) 7.09
Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Trop Med Int Health (2008) 5.32
Monitoring cholesterol levels: measurement error or true change? Ann Intern Med (2008) 3.35
Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysis. Arch Intern Med (2008) 2.96
Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach. Stat Med (1996) 2.66
Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 Cell count slope for progression to AIDS and death in untreated HIV-1 infection. JAMA (2007) 2.59
Forecasting individual pharmacokinetics. Clin Pharmacol Ther (1979) 2.41
Genomics meets HIV-1. Nat Rev Microbiol (2006) 2.34
Association of race and gender with HIV-1 RNA levels and immunologic progression. J Acquir Immune Defic Syndr (2000) 2.13
When should antiretroviral therapy for HIV be started? BMJ (2007) 1.95
Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters. AIDS (2005) 1.75
Effect of CD4+ cell count measurement variability on staging HIV-1 infection. J Acquir Immune Defic Syndr (1992) 1.65
HIV-1 pol replication capacity predicts disease progression. AIDS (2005) 1.63
Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion. J Acquir Immune Defic Syndr (2003) 1.59
Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model. Ann Intern Med (2008) 1.55
Clinical practice. Management of newly diagnosed HIV infection. N Engl J Med (2005) 1.53
Effect of pregnancy on HIV disease progression and survival among women in rural Uganda. Trop Med Int Health (2007) 1.35
The impact of monitoring HIV patients prior to treatment in resource-poor settings: insights from mathematical modelling. PLoS Med (2008) 1.32
Late entry to HIV care limits the impact of anti-retroviral therapy in The Netherlands. PLoS One (2008) 1.27
Suitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agenda. Clin Infect Dis (2003) 1.20
Variation in plasma RNA levels, CD4 cell counts, and p24 antigen levels in clinically stable men with human immunodeficiency virus infection. J Infect Dis (1996) 1.18
HIV in the UK 1980-2006: reconstruction using a model of HIV infection and the effect of antiretroviral therapy. HIV Med (2007) 1.11
A joint back calculation model for the imputation of the date of HIV infection in a prevalent cohort. Stat Med (2008) 1.10
Longitudinal models for AIDS marker data. Stat Methods Med Res (1998) 1.07
Is there a general tendency for CD4 lymphocyte decline to speed up during human immunodeficiency virus infection? Evidence from the Italian Seroconversion Study. J Infect Dis (1997) 0.97
Effects of age at seroconversion and baseline HIV RNA level on the loss of CD4+ cells among persons with hemophilia. Multicenter Hemophilia Cohort Study. AIDS (1998) 0.96
CD4(+) T cell count decreases by ethnicity among untreated patients with HIV infection in South Africa and Switzerland. J Infect Dis (2009) 0.94
Slow progression of HIV-1 infection in a cohort of antiretroviral naïve hotel workers in Dar es Salaam, Tanzania as defined by their CD4 cell slopes. Scand J Infect Dis (2008) 0.93
Bayes estimates for immunological progression rates in HIV disease. Stat Med (1997) 0.92
Statistical models for the control phase of clinical monitoring. Stat Methods Med Res (2010) 0.88
Diagnostic tests in HIV management: a review of clinical and laboratory strategies to monitor HIV-infected individuals in developing countries. Bull World Health Organ (2006) 0.87
Clinical, immunological and virological evolution in patients with CD4 T-cell count above 500/mm3: is there a benefit to treat with highly active antiretroviral therapy (HAART)? Eur J Epidemiol (2004) 0.82
Virologic and immunologic values allowing safe deferral of antiretroviral therapy. AIDS (2002) 0.80
A national review of assessment and monitoring of HIV-infected patients. HIV Med (2008) 0.78
A whole-genome association study of major determinants for host control of HIV-1. Science (2007) 15.19
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ (2003) 10.80
The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med (2003) 10.28
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA (2010) 9.26
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA (2012) 8.94
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med (2003) 8.58
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem (2003) 8.13
The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem (2003) 7.92
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology (2010) 7.86
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ (2014) 7.55
WGAViewer: software for genomic annotation of whole genome association studies. Genome Res (2008) 7.15
Chloramphenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trial. Lancet (2005) 6.86
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet (2007) 6.83
Clinical recognition of meningococcal disease in children and adolescents. Lancet (2006) 6.27
Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA (2010) 5.90
No surgical innovation without evaluation: the IDEAL recommendations. Lancet (2009) 5.57
Towards an HIV cure: a global scientific strategy. Nat Rev Immunol (2012) 5.52
Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev (2013) 5.44
A prescription for better prescribing. BMJ (2006) 5.31
Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet (2011) 4.78
Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis (2010) 4.56
Corticosteroids as standalone or add-on treatment for sore throat. Cochrane Database Syst Rev (2012) 4.50
Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol (2010) 4.34
Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis (2011) 4.31
Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev (2012) 4.25
Prolotherapy injections, saline injections, and exercises for chronic low-back pain: a randomized trial. Spine (Phila Pa 1976) (2004) 3.75
A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol (2012) 3.72
Common genetic variation and the control of HIV-1 in humans. PLoS Genet (2009) 3.68
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clin Infect Dis (2005) 3.57
Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared. PLoS Med (2008) 3.56
A systematic review of interventions for smokers who contact quitlines. Tob Control (2007) 3.47
Personalised care planning for adults with chronic or long-term health conditions. Cochrane Database Syst Rev (2015) 3.47
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Arch Intern Med (2003) 3.41
Poor description of non-pharmacological interventions: analysis of consecutive sample of randomised trials. BMJ (2013) 3.39
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet (2002) 3.32
Taking healthcare interventions from trial to practice. BMJ (2010) 3.27
Cardiovascular disease risk in healthy children and its association with body mass index: systematic review and meta-analysis. BMJ (2012) 3.22
Antibiotics for acute otitis media in children. Cochrane Database Syst Rev (2013) 3.15
Corticosteroids for pain relief in sore throat: systematic review and meta-analysis. BMJ (2009) 3.13
Cohort profile: the Swiss HIV Cohort study. Int J Epidemiol (2009) 3.05
Evaluation and stages of surgical innovations. Lancet (2009) 3.04
Should we screen for prostate cancer? A re-examination of the evidence. Med J Aust (2013) 3.03
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet (2009) 3.03
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Fam Pract (2004) 2.99
Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients. Pharmacogenet Genomics (2005) 2.94
Adaptation and validation of the Charlson Index for Read/OXMIS coded databases. BMC Fam Pract (2010) 2.93
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clin Infect Dis (2006) 2.93
Challenges in evaluating surgical innovation. Lancet (2009) 2.86
Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect Dis (2007) 2.85
Case reports of suspected adverse drug reactions--systematic literature survey of follow-up. BMJ (2006) 2.79
Forty years of sports performance research and little insight gained. BMJ (2012) 2.79
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Radiology (2003) 2.73
Telephone counselling for smoking cessation. Cochrane Database Syst Rev (2013) 2.73
The road to health care. BMJ (2004) 2.71
Competitions and incentives for smoking cessation. Cochrane Database Syst Rev (2011) 2.67
A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med (2004) 2.66
Safety of hormone replacement therapy after mastectomy. Med J Aust (2002) 2.66
Anecdotes as evidence. BMJ (2003) 2.66
Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein. Cell Host Microbe (2012) 2.66
Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review. Circ Cardiovasc Qual Outcomes (2008) 2.61
Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia. J Infect Dis (2005) 2.58
Expanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United States. PLoS Med (2013) 2.49
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med (2013) 2.49
Hypertension guideline recommendations in general practice: awareness, agreement, adoption, and adherence. Br J Gen Pract (2007) 2.37
Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature (2011) 2.36
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. Clin Infect Dis (2008) 2.35
Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study. Clin Infect Dis (2005) 2.35
Self-monitoring and self-management of oral anticoagulation. Cochrane Database Syst Rev (2010) 2.32
Antibiotics for sore throat. Cochrane Database Syst Rev (2013) 2.23
Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland. J Infect Dis (2010) 2.21
Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study. BMJ (2007) 2.19
SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage. Blood (2013) 2.18
Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections. Clin Infect Dis (2012) 2.11
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin Chem Lab Med (2003) 2.10
Clarification of terminology in medication errors: definitions and classification. Drug Saf (2006) 2.06
Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection. Clin Pharmacol Ther (2003) 2.05
Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008. Arch Intern Med (2010) 2.05
Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic. Clin Infect Dis (2012) 2.04
Update of the drug resistance mutations in HIV-1: Fall 2005. Top HIV Med (2005) 2.04
Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides. PLoS Biol (2012) 2.03
Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study. Clin Infect Dis (2007) 1.98
APOBEC3G genetic variants and their influence on the progression to AIDS. J Virol (2004) 1.97
Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr (2006) 1.95
Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients. Clin Cancer Res (2004) 1.95
Using vital signs to assess children with acute infections: a survey of current practice. Br J Gen Pract (2008) 1.94
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population. Lancet (2003) 1.94
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders. J Infect Dis (2005) 1.93